Bionano Genomics Inc (BNGO)

$3.60 0. (0.00%)

16:00 EDT BNGO Stock Quote Delayed 30 Minutes

Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value

By Louis Navellier and the InvestorPlace Research Staff Oct 19, 2021

BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche.

Bionano Genomics Stock Looks Ready to Reward Patient Investors

BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring

Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever

Volume:

Previous Close -

Market Cap 1.00B

PE Ratio -12.41

EPS -0.29

Volume (Avg. Vol.) 15.75M

Day's Range $3.42 - $3.73

52-Week Range $1.16 - $6.28

Dividend & Yield N/A (N/A)

BNGO Stock Predictions, Articles, and Bionano Genomics Inc News

From InvestorPlace
From the Web

BNGO Stock: What Is Driving Bionano Genomics Higher Today?

By Chris MacDonald, InvestorPlace Contributor Sep 30, 2021

Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping.

3 Top Tech Stocks to Buy on Weakness

By Larry Ramer, InvestorPlace Contributor Sep 21, 2021

All three of these tech names, driven by very strong positive catalysts, should rally over the longer term, leading to high profits for investors.

Bionano Genomics Remains Promising With Global Product Adoption

By Louis Navellier and the InvestorPlace Research Staff Sep 21, 2021

BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system.

The Price Is Right for BioNano Genomics Given Saphyr’s Potential

By Louis Navellier and the InvestorPlace Research Staff Aug 30, 2021

With its Saphyr system seeing adoption ramp up, the long-term growth potential for BNGO stock is considerable.

Bionano Stock Will Soar as the Company’s Diagnostic System Catches On

By Larry Ramer, InvestorPlace Contributor Aug 18, 2021

As more payors reimburse labs for using Bionano's Saphyr device, the company's financial results will improve, lifting BNGO stock.

Faster and Better Clinical Outcomes Make the Case for Bionano Genomics

By Louis Navellier and the InvestorPlace Research Staff Aug 5, 2021

Bionano Genomics is mastering the science of genome mapping, while a reduced-price BNGO stock has a clear path forward for investors.

Bionano’s Technology Is Interesting, But Its Earnings Are Uninspiring

By Ian Bezek, InvestorPlace Contributor Aug 2, 2021

Bionano could become a decent testing company within its niche. However, BNGO stock has run far ahead of the company's fundamentals.

Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics

By Stavros Georgiadis, CFA, InvestorPlace Contributor Jul 23, 2021

Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.

You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush

By Larry Ramer, InvestorPlace Contributor Jul 16, 2021

With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip.

4 Highly Promising Meme Stocks to Buy Now

By Larry Ramer, InvestorPlace Contributor Jul 13, 2021

Not all meme stocks are overvalued. These four meme stocks are good buys, as they're poised to deliver big profits for investors.

Bionano Genomics Stock Has Short-Term Opportunities

By Nicolas Chahine, InvestorPlace Contributor Jun 28, 2021

BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward.

BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheering

By William White, InvestorPlace Writer Jun 28, 2021

Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know.

Wait for the Reddit Set to Sell Before Buying Bionano Stock

By Thomas Niel Jun 28, 2021

With the "story" behind it still years in the making, take your time with BNGO stock. At some point, its meme stock investors will cash out, sending it back to more reasonable prices.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor, Today's Market Jun 28, 2021

So what will the stock market do today? All eyes are on gene-editing stocks like NTLA and on recovering crypto prices.

Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks

By Robert Lakin, InvestorPlace Contributor Jun 28, 2021

Gene editing stocks are getting a boost on Monday morning after Intellia Therapeutics said it was successful using CRISPR gene-editing therapy directed inside the body to an internal organ.